Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Puma Biotechnology (PBYI) Accumulated Depreciation & Amortization (2017 - 2025)

Historic Accumulated Depreciation & Amortization for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $6.6 million.

  • Puma Biotechnology's Accumulated Depreciation & Amortization fell 1737.93% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 1737.93%. This contributed to the annual value of $7.9 million for FY2024, which is 244.79% up from last year.
  • According to the latest figures from Q3 2025, Puma Biotechnology's Accumulated Depreciation & Amortization is $6.6 million, which was down 1737.93% from $8.1 million recorded in Q2 2025.
  • Puma Biotechnology's Accumulated Depreciation & Amortization's 5-year high stood at $8.1 million during Q2 2025, with a 5-year trough of $6.3 million in Q1 2021.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $7.6 million (2023), whereas its average is $7.4 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 1154.28% in 2021, then tumbled by 1737.93% in 2025.
  • Over the past 5 years, Puma Biotechnology's Accumulated Depreciation & Amortization (Quarter) stood at $6.9 million in 2021, then grew by 8.23% to $7.4 million in 2022, then increased by 3.42% to $7.7 million in 2023, then grew by 2.45% to $7.9 million in 2024, then fell by 16.26% to $6.6 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $6.6 million for Q3 2025, versus $8.1 million for Q2 2025 and $8.0 million for Q1 2025.